Regulation of ultraviolet radiation induced cutaneous photoimmunosuppression by Toll-like receptor-4

被引:40
|
作者
Lewis, Wesley [1 ,2 ]
Simanyi, Eva [1 ,2 ]
Li, Hui [1 ,2 ]
Thompson, Camilla A. [1 ,2 ]
Nasti, Tahseen H. [1 ,2 ]
Jaleel, Tarannum [1 ,2 ]
Xu, Hui [1 ,2 ]
Yusuf, Nabiha [1 ,2 ,3 ,4 ]
机构
[1] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Skin Dis Res Ctr, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Vet Affairs Med Ctr, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA
关键词
Toll like receptor-4; Ultraviolet B radiation; Contact hypersensitivity; Immunosuppression; CONTACT HYPERSENSITIVITY; SKIN-CANCER; IMMUNE SUPPRESSION; T-CELLS; INDUCTION; TLR4; IMMUNOSUPPRESSION; LYMPHOCYTES; TOLERANCE; MICE;
D O I
10.1016/j.abb.2011.01.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
UVB radiation is a potent immunosuppressive agent that inhibits cell-mediated immune responses. The mechanisms by which UVB radiation influences cell-mediated immune responses have been the subject of extensive investigation. However, the role of innate immunity on photoimmunological processes has received little attention. The purpose of this study was to determine whether Toll-like receptor-4 (TLR4) contributed to UV-induced suppression of contact hypersensitivity (CHS) responses. TLR4(-/-) and wild type C57BL/6 (TLR4(+/+)) mice were subjected to a local UVB immunosuppression regimen consisting of 100 mj/cm(2) UVB radiation followed by sensitization with the hapten DNFB. Wild type TLR4(+/+) mice exhibited significant suppression of contact hypersensitivity response, whereas TLR-/- developed significantly less suppression. The suppression in wild type TLRL+/+ mice could be adoptively transferred to naive syngeneic recipients. Moreover, there were significantly fewer Foxp3 expressing CD4(+)CD25(+) regulatory T-cells in the draining lymph nodes of UV-irradiated TLR4(-/-) mice than TLR4(+/+) mice. When cytokine levels were compared in these two strains after UVB exposure, T-cells from TLR+/+ mice produced higher levels of IL-10 and TGF-beta and lower levels of IFN-gamma and IL-17. Strategies to inhibit TLR4 may allow us to develop immunopreventive and immunotherapeutic approaches for management of UVB induced cutaneous immunosuppression. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:171 / 177
页数:7
相关论文
共 50 条
  • [31] ANEMIA IN HEPATOBLASTOMA: THE ROLE OF HEPCIDIN AND TOLL-LIKE RECEPTOR-4
    Hsiao, C.
    Kao, Y.
    Huang, S.
    Chuang, J.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 108 - 108
  • [32] Toll-Like Receptor-4 Is a Mediator of Proliferation in Esophageal Adenocarcinoma
    Kohtz, Patrick D.
    Halpern, Alison L.
    Eldeiry, Mohamed A.
    Hazel, Kweku
    Kalatardi, Shana
    Ao, Lihua
    Meng, Xianzhong
    Reece, T. Brett
    Fullerton, David A.
    Weyant, Michael J.
    ANNALS OF THORACIC SURGERY, 2019, 107 (01): : 233 - 241
  • [33] Toll-like receptor-4 expression in infants with pertussis infection
    Z. Vadasz
    E. Bamberger
    K. Ben-Tikva
    M. Feterman
    I. Srugo
    A. Kessel
    Infection, 2013, 41 : 195 - 198
  • [34] Lipopolysaccharide induced changes in toll-like receptor-4 distribution in chorionic villi and amniochorion
    Adams, K
    Lucas, J
    Kapur, R
    Eschenbach, D
    Stevens, A
    PLACENTA, 2004, 25 (8-9) : A63 - A63
  • [35] Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice
    Riad, Alexander
    Bien, Sandra
    Gratz, Matthias
    Escher, Felicitas
    Westermann, Dirk
    Heimesaat, Markus M.
    Bereswill, Stefan
    Krieg, Thomas
    Felix, Stephan B.
    Schultheiss, Heinz P.
    Kroemer, Hevo K.
    Tschoepe, Carsten
    EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (03) : 233 - 243
  • [36] Inclisiran reduces expression of Toll-like receptor-4 on circulating monocytes
    Bernhard, J.
    Engelberger, K.
    Galli, L.
    Haider, P.
    Ungersbaeck, K.
    Hengstenberg, C.
    Speidl, W. S.
    Krychtiuk, K. A.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S417 - S417
  • [37] Toll-like Receptor-4: A New Target for Preterm Labour Pharmacotherapies?
    Robertson, Sarah A.
    Wahid, Hanan H.
    Chin, Peck Yin
    Hutchinson, Mark R.
    Moldenhauer, Lachlan M.
    Keelan, Jeffrey A.
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (09) : 960 - 973
  • [38] Toll-like receptor-4 and cytokine cascade in stroke after exercise
    Zwagerman, Nathan
    Plumlee, Chuck
    Guthikonda, Murali
    Ding, Yuchuan
    NEUROLOGICAL RESEARCH, 2010, 32 (02) : 123 - 126
  • [39] Toll-like receptor-4 expression and oxidative stress in ocular rosacea
    Yesilirmak, Nilufer
    Bukan, Neslihan
    Kurt, Busra
    Fatsa, Tugba
    Yuzbasioglu, Sema
    Zhao, Min
    Hosbul, Tugrul
    Bourges, Jean-Louis
    Behar-Cohen, Francine
    MOLECULAR VISION, 2023, 29 : 357 - 364
  • [40] Inclisiran reduces expression of Toll-like receptor-4 on circulating monocytes
    Bernhard, J.
    Engelberger, K.
    Galli, L.
    Haider, P.
    Ungersbaeck, K.
    Hengstenberg, C.
    Speidl, W. S.
    Krychtiuk, K. A.
    EUROPEAN HEART JOURNAL, 2023, 44